tiprankstipranks
Femasys participates in a conference call with JonesResearch
PremiumThe FlyFemasys participates in a conference call with JonesResearch
1M ago
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
PremiumPress Releases
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
1M ago
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
PremiumPress Releases
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
1M ago
Femasys Reveals Corporate Update and FDA-Cleared Infertility Solution
PremiumCompany AnnouncementsFemasys Reveals Corporate Update and FDA-Cleared Infertility Solution
2M ago
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
PremiumPress Releases
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
2M ago
Femasys’ FemaSeed to serve as first-line therapeutic option
PremiumThe Fly
Femasys’ FemaSeed to serve as first-line therapeutic option
2M ago
Femasys begins enrollment for FemBloc trial
PremiumThe FlyFemasys begins enrollment for FemBloc trial
3M ago
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
PremiumPress Releases
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
3M ago
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
PremiumPress Releases
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100